Skip to main content

Table 2 Seropositivity and estimated serological conversion rate (eSCR) for PfMSP-119, CSP, and LSA-1 antibodies

From: Analysis of anti-Plasmodium IgG profiles among Fulani nomadic pastoralists in northern Senegal to assess malaria exposure

 

Dagana

Kanel

Pete

Podor

Ranerou

PfMSP-119

 Seropositivity % (95% CI)

37.9 (32.3–43.7)

63.4 (57.6–68.9)

55.8 (49.9–61.6)

28.0 (23.0–33.5)

39.9 (34.3–45.8)

 eSCR

0.022 (0.008–0.04)

0.063 (0.04–0.08)

0.047 (0.03–0.06)

0.015 (0.008–0.02)

0.029 (0.02–0.04)

CSP

 Seropositivity % (95% CI)

9.9 (6.7–13.9)

14.6 (10.8–19.1)

20.4 (16.0–25.5)

10.1 (6.9–14.2)

5.1 (2.9–8.3)

 eSCR

0.0040 (0.004–0.008)

0.0055 (0.002–0.009)

0.0093 (0.002–0.02)

0.0045 (0.0004–0.008)

0.0026 (0.006–0.01)

LSA-1

 Seropositivity % (95% CI)

3.8 (1.9–6.6)

6.4 (3.9–9.9)

8.8 (5.9–12.7)

2.7 (1.2–5.3)

1.4 (0.4–3.5)

 eSCR

0.0015 (0.0004–0.004)

0.0014 (0.0004–0.003)

0.0035 (0.0004–0.007)

0.0064 (0.002–0.01)

0.0013 (0.002–0.004)